Nature Communications · 2019 · 144 citations · 50 references
PharmacyBiotechnologyNeuroscienceDrug DeliveryGene DeliveryGene TherapyGene Delivery SystemsGene Delivery To Stem CellsGene Delivery VectorsNeurological Gene TherapyNucleic Acid DeliveryPolymeric Gene CarriersGene Delivery BiomaterialsGene Delivery CarriersGene Delivery To The BrainNerve Growth Factor SignalingNeurite Outgrowth InhibitionNeurodegenerative Disease Gene TherapyTransfection OptimizationTransfection Reagents
Current therapies for most neurodegenerative disorders are only symptomatic in nature and do not change the course of the disease. Gene therapy plays an important role in disease modifying therapeutic strategies. Herein, we have designed and optimized a series of highly branched poly(β-amino ester)s (HPAEs) containing biodegradable disulfide units in the HPAE backbone (HPAESS) and guanidine moieties (HPAESG) at the extremities. The optimized polymers are used to deliver minicircle DNA to multipotent adipose derived stem cells (ADSCs) and astrocytes, and high transfection efficiency is achieved (77% in human ADSCs and 52% in primary astrocytes) whilst preserving over 90% cell viability. Furthermore, the top-performing candidate mediates high levels of nerve growth factor (NGF) secretion from astrocytes, causing neurite outgrowth from a model neuron cell line. This synergistic gene delivery system provides a viable method for highly efficient non-viral transfection of ADSCs and astrocytes.
50
Paul A. Wender, Dennis J. Mitchell, Kanaka Pattabiraman et al. · Proceedings of the National Academy of Sciences · 2000 · 1.6K citations · Full text
Recent Advances in Nonviral Vectors for Gene Delivery
Xia Guo, Leaf Huang · Accounts of Chemical Research · 2011 · 580 citations